Jade Therapeutics

company

About

Jade Therapeutics develops locally administered, polymer-based products designed to treat poorly-served ophthalmic indications.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$153.64K
Industries
Biotechnology,Health Care,Medical,Visual Search
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Jade Therapeutics develops ophthalmic sustained-release drug delivery platforms. The company focuses on the development of locally administered, sustained-release therapeutics that improve corneal healing following damage from disease or injury and improve visual function and quality of life. Its product delivers recombinant human growth hormone, a well-characterized biologic, that has healing properties via the activation and recruitment of key cells involved in the tissue-building process.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.05M
Jade Therapeutics has raised a total of $1.05M in funding over 2 rounds. Their latest funding was raised on Nov 25, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 25, 2014 Grant $0.90M 1 National Science Foundation Detail
Jun 12, 2013 Grant $153.64K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Jade Therapeutics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant